| In the face of challenges and opportunities,Yunnan X Biopharmaceutical Group should take the existing achievements as the basis,to achieve a leap in development,to complete the"second venture" strategic objectives.Therefore,to learn from the successful cases in the industry,promote the further maturity of the industrial cluster,and enhance the competitiveness of Yunnan X Biopharmaceutical Group,which is the core issue that Yunnan X Biopharmaceutical Group needs to face and urgently need to solve.or this reason,this paper draws lessons from relevant successful experience at home and abroad,combines the strategic management characteristics of Yunnan X Biopharmaceutical Group in the process of formulating its development model,such as collectivization and industrial chain extension,and puts forward reasonable optimization of various resource allocation to better promote the formation of economies of scale and agglomeration effects in order to reduce them.The transaction cost and production cost of Yunnan X Biopharmaceuticals Group in the field of pharmaceutical industry,thereby enhancing the competitiveness of Yunnan X Biopharmaceuticals Group in the pharmaceutical industry.Yunnan X Biopharmaceutical Group should also pay attention to the establishment of its own innovation system,realize the organic combination of production,academic research and product development,shape the unique cultural innovation consciousness of Yunnan X Biopharmaceutical Group,promote the establishment of industrial intensive and clustering,and realize the rational utilization of clustering effect.In addition,it is proposed that under the new economic background,the development strategy of Yunnan X Biopharmaceutical Group should be rationally adjusted to provide strategic choices for the construction of sustainable competitive advantages and promote industrial development and upgrading,so as to realize the long-term and stable development of Yunnan X Biopharmaceutical Group. |
PDF Full Text Request